Polarean Imaging PLC (LON:POLX) fell 2.1% during trading on Monday . The stock traded as low as GBX 27.31 ($0.34) and last traded at GBX 28 ($0.34), 234,470 shares traded hands during mid-day trading. The stock had previously closed at GBX 28.60 ($0.35).

The company has a debt-to-equity ratio of 2.64, a current ratio of 1.67 and a quick ratio of 1.37. The company’s 50 day moving average is GBX 26.73 and its 200 day moving average is GBX 24.99. The stock has a market cap of $42.74 million and a price-to-earnings ratio of -4.91.

Polarean Imaging Company Profile (LON:POLX)

Polarean Imaging Plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company manufactures, sells, and services hyperpolarizers and ancillary equipment for biomedical imaging research. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach.

Featured Article: What does an outperform rating mean?

Receive News & Ratings for Polarean Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarean Imaging and related companies with MarketBeat.com's FREE daily email newsletter.